Xiaoben Diping Huanshi Pian (硝苯地平缓释片Ⅰ)硝苯地平缓释片Ⅰ
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
批准文号:NMPA approval number: 国药准字H14020439
生产企业Manufacturer
- 亚宝药业集团股份有限公司Chinese legal name: 亚宝药业集团股份有限公司
主要成分Active Ingredients
- 二甲基--(-硝基苯基
- 二氢Er Qing
- 吡啶二甲酸二甲酯Biding Erjia Suaner Jiazhi
药物知识说明
国药准字H14020439是一种在国家药监局注册认定的药品。该药品含有二氢、二甲基--(-硝基苯基-29aaacd0等成分。
该药品关联的活性成分包括：二氢Er Qing、二甲基--(-硝基苯基Erjia Jixiao Jiben Ji。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：亚宝药业集团股份有限公司Chinese legal name: 亚宝药业集团股份有限公司。
您可以探索含有相同成分的其他药品：二氢-fecab7ab成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 硝苯地平缓释片Ⅰ) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 二氢Er Qing, 二甲基--(-硝基苯基Erjia Jixiao Jiben Ji.
Manufacturers recorded for this product: 亚宝药业集团股份有限公司Chinese legal name: 亚宝药业集团股份有限公司.
Explore other medicines containing the same ingredient: 二氢 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 硝苯地平缓释片ⅠRecorded Chinese name: 硝苯地平缓释片Ⅰ
- 规格Specification: 10mg*30片10 mg × 30 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 亚宝药业集团股份有限公司Chinese legal name: 亚宝药业集团股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H14020439
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H14020439
Manufacturer
Chinese legal name: 亚宝药业集团股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
10 mg × 30 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字H14020439
生产企业
亚宝药业集团股份有限公司(国产)
适应症
1.高血压 |2.冠心病 慢性稳定型心绞痛(劳累性心绞痛)
用法用量
治疗时应尽可能按个体情况用药。依据患者的临床情况，给予不同的基础用药剂量。肝功能损伤患者应仔细监控，严重病例应减少用药剂量。 除非特殊医嘱，成年人推荐下列剂量：一次一片（30mg），一日1次。
不良反应
1.肝脏：偶尔出现黄疸及谷氨酸草酰乙酸氨基转移酶、谷氨酸丙酮酸氨基转移酶升高。 |2.循环系统：偶尔出现胸部疼痛、头痛、脸红、眼花、心悸、血压下降至正常以下、下肢浮肿等。 |3.过敏症：偶尔出现荨麻疹、瘙痒等过敏症状。 |4.消化系统：偶尔出现腹痛、恶心、食欲不振、便秘等症。 |5.口腔：可能出现牙龈肥厚。 |6.代谢异常：偶尔出现高血糖症状。
禁忌
对硝苯地平过敏者禁用。
注意事项
1.中止服用钙拮抗剂时应逐渐减量，没有医生指示，不要中止服药。 |2.低血压患者慎用。 |3.严重主动脉瓣狭窄、肝肾功能不全患者慎用。
贮藏
密封、避光、置阴凉干燥通风处
规格
10mg*30片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.